Peter Wolfe, the Chief Financial Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, Wolfe's number of shares held after the transaction remains unknown. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.

Peter Wolfe, the Chief Financial Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, Wolfe's number of shares held after the transaction remains unknown. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.